Helixmith gene therapy

· Helixmith Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Helixmith gene therapy, covering 2023-03-08 to 2023-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy [Phase 3]